Shriberg LD, Aram DM, Kwiatkowski J. Developmental apraxia of speech: I. Descriptive and theoretical views. J Speech Lang Listening to Res. 1997;40:273–85.
Chenausky KV, Brignell A, Morgan A, Gagné D, Norton A, Tager-Flusberg H, et al. Issue evaluation of indicators of childhood apraxia of speech. J Commun Disord. 2020;87:106033.
Lewis BA, Ekelman BL. Literacy issues related to childhood apraxia of speech. Perspect Lang Be taught Educ. 2007;14:10–7.
Morgan AT, Webster R. Aetiology of childhood apraxia of speech: A scientific observe replace for paediatricians. J Paediatrics Baby Well being. 2018;54:1090–5.
Reilly S, McKean C, Morgan A, Wake M. Figuring out and managing widespread childhood language and speech impairments. BMJ. 2015;350:h2318.
Morgan A, Eecen KT, Pezic A, Brommeyer Ok, Mei C, Eadie P, et al. Who to refer for speech remedy at 4 years of age versus who to “watch and wait”? J Pediatrics. 2017;185:200–4. e1.
Roulstone SE, Marshall JE, Powell GG, Goldbart J, Wren YE, Coad J, et al. Proof-based intervention for preschool youngsters with major speech and language impairments: Baby Discuss–an exploratory mixed-methods examine. Program Grants Appl Res. 2015;3:1–408.
Consortium S. Extremely vital linkage to the SLI1 locus in an expanded pattern of people affected by particular language impairment. Am J Hum Genet. 2004;74:1225–38.
Bishop DV, Adams CV, Norbury CF. Distinct genetic influences on grammar and phonological brief‐time period reminiscence deficits: proof from 6‐12 months‐previous twins. Genes Mind Behav. 2006;5:158–69.
Graham SA, Deriziotis P, Fisher SE. Insights into the genetic foundations of human communication. Neuropsychol Rev. 2015;25:3–26.
Morgan A, Fisher SE, Scheffer I, Hildebrand M. M. FOXP2-related Speech and Language Problems. In GeneReviews(R) (eds Pagon RA, et al.) (Seattle, WA, 2017).
Kaspi A, Hildebrand MS, Jackson VE, Braden R, Van Reyk O, Howell T, et al. Genetic aetiologies for childhood speech dysfunction: novel pathways co-expressed throughout mind growth. Mol Psychiatry. 2023;28:1647–63.
Eising E, Carrion-Castillo A, Vino A, Strand EA, Jakielski KJ, Scerri TS, et al. A set of regulatory genes co-expressed in embryonic human mind is implicated in disrupted speech growth. Mol Psychiatry. 2019;24:1065–78.
Hildebrand MS, Jackson VE, Scerri TS, Van Reyk O, Coleman M, Braden RO, et al. Extreme childhood speech dysfunction: Gene discovery highlights transcriptional dysregulation. Neurology. 2020;94:e2148–e67.
Regier D, Friedman J, Makela N, Ryan M, Marra C. Valuing the good thing about diagnostic testing for genetic causes of idiopathic developmental incapacity: willingness to pay from households of affected youngsters. Clin Genet. 2009;75:514–21.
Greatest S, Stark Z, Phillips P, Wu Y, Lengthy JC, Taylor N, et al. Scientific genomic testing: what issues to key stakeholders? Eur J Hum Genet. 2020;28:866–73.
Goranitis I, Greatest S, Christodoulou J, Stark Z, Boughtwood T. The non-public utility and uptake of genomic sequencing in pediatric and grownup circumstances: eliciting societal preferences with three discrete alternative experiments. Genet Med. 2020;22:1311–9.
Goranitis I, Greatest S, Stark Z, Boughtwood T, Christodoulou J. The worth of genomic sequencing in complicated pediatric neurological issues: a discrete alternative experiment. Genet Med. 2021;23:155–62.
Goranitis I, Greatest S, Christodoulou J, Boughtwood T, Stark Z. Preferences and values for speedy genomic testing in critically unwell infants and kids: a discrete alternative experiment. Eur J Hum Genet. 2021;29:1645–53.
Meng Y, Clarke PM, Goranitis I. The Worth of Genomic Testing: A Contingent Valuation Throughout Six Baby-and Grownup-Onset Genetic Situations. PharmacoEconomics. 2022;40:215–23.
Goranitis I, Wu Y, Lunke S, White SM, Tan TY, Yeung A, et al. Is quicker higher? An financial analysis of speedy and ultra-rapid genomic testing in critically unwell infants and kids. Genet Med. 2022;24:1037–44.
Wu Y, Balasubramaniam S, Rius R, Thorburn DR, Christodoulou J, Goranitis I. Genomic sequencing for the prognosis of childhood mitochondrial issues: a well being financial analysis. Eur J Hum Genet. 2022;30:577–86.
Johnson FR, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier DA, et al. Setting up experimental designs for discrete-choice experiments: report of the ISPOR conjoint evaluation experimental design good analysis practices job drive. Worth well being. 2013;16:3–13.
Coast J, Horrocks S. Growing attributes and ranges for discrete alternative experiments utilizing qualitative strategies. J Well being Serv Res coverage. 2007;12:25–30.
Cummings RG, Taylor LO. Unbiased worth estimates for environmental items: an inexpensive speak design for the contingent valuation technique. Am Econ Rev. 1999;89:649–65.
Weber S. A step-by-step process to implement discrete alternative experiments in Qualtrics. Soc Sci Pc Rev. 2021;39:903–21.
Bliemer MC, Collins AT. On figuring out priors for the era of environment friendly acknowledged alternative experimental designs. J Alternative Mannequin. 2016;21:10–4.
Rose JM, Bliemer MC. Pattern dimension necessities for acknowledged alternative experiments. Transportation. 2013;40:1021–41.
Hensher D, Rose J, Greene W. Utilized Alternative Evaluation. 2nd ed. Cambridge, UK; Cambridge College Press, The College Printing Home; 2015.
Gonzalez JM. A information to measuring and decoding attribute significance. Affected person. 2019;12:287–95.
Small KA, Rosen HS. Utilized welfare economics with discrete alternative fashions. Econometrica. 1981;49:105–30.
Marshall DA, MacDonald KV, Heidenreich S, Hartley T, Bernier FP, Gillespie MK, et al. The worth of diagnostic testing for fogeys of kids with uncommon genetic ailments. Genet Med. 2019;21:2798–806.
Mazumdar T, Raj SP, Sinha I. Reference worth analysis: Assessment and propositions. J Mark. 2005;69:84–102.
Adaval R, Wyer RS Jr. Aware and nonconscious comparisons with worth anchors: Results on willingness to pay for associated and unrelated merchandise. J Mark Res. 2011;48:355–65.
Feero WG, Wicklund C, Veenstra DL. The economics of genomic medication: insights from the IOM Roundtable on Translating Genomic-Based mostly Analysis for Well being. JAMA. 2013;309:1235–6.
Kohler JN, Turbitt E, Biesecker BB. Private utility in genomic testing: a scientific literature evaluate. Eur J Hum Genet. 2017;25:662–8.
Powell G, Holmes EA, Plumpton CO, Ring A, Baker GA, Jacoby A, et al. Pharmacogenetic testing previous to carbamazepine remedy of epilepsy: sufferers’ and physicians’ preferences for testing and repair supply. Br J Clin Pharmacol. 2015;80:1149–59.
Shilling V, Bailey S, Logan S, Morris C. Peer assist for fogeys of disabled youngsters half 1: perceived outcomes of a one‐to‐one service, a qualitative examine. Baby Care Well being Dev. 2015;41:524–36.
Zhu X, Smith RA, Parrott RL. Residing with a uncommon well being situation: the affect of a assist group and public stigma on communication, stress, and out there assist. J Appl Commun Res. 2017;45:179–98.
Daniel GR, McLeod S. Kids with speech sound issues at college: Challenges for kids, mother and father and academics. Aust J Educate Educ. 2017;42:81–101.
Quaife M, Terris-Prestholt F, Di Tanna GL, Vickerman P. How properly do discrete alternative experiments predict well being selections? A scientific evaluate and meta-analysis of exterior validity. Eur J Well being Econ. 2018;19:1053–66.
